Ocular immune privilege
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
The eye attempts to limit local immune and inflammatory responses to preserve vision. This phenomenon, known as ocular immune privilege, is mediated by a combination of local and systemic mechanisms. While immune privilege is believed to protect the eye from day-to-day inflammatory insults, it is not absolute and its mechanisms are still incompletely understood.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The small size, accessibility, confined structure, and immune-privileged status of the eye [74, 75], make it an ideal target for gene therapy”
From The economic impact of retinal diseases for which gene therapy is emerging: a systematic literature review (2025) · cites this paper as [75]
Experimental — accuracy not yet measuredIn the citing paper
“it has been shown that the eye exhibits physical barriers (e.g., blood-retina-barrier preventing free entry of systemic immune cells) as well as cell-bound and soluble immunosuppressive factors11,12.”
From Investigation of Cas9 Antibodies in the Human Eye (2022) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Medawar, P. B. (1948) · PubMed · Cited by 1,109
Ocular immune privilege: therapeutic opportunities from an experiment of nature
Streilein, J. W. (2003) · Nature Reviews Immunology · doi:10.1038/nri1224 · Cited by 807 · cited 1×
“that have recovered fromexperimental autoimmuneuveitis (EAU) contain regulatory activity, whose generation is dependent on the presence of eye [7-9].”
BackgroundOcular immune privilege: the eye takes a dim but practical view of immunity and inflammation
Streilein, J. W. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.1102574 · Cited by 367
Spontaneous autoimmunity prevented by thymic expression of a single self-antigen
DeVoss, J., Hou, Y., Johannes, K., Lu, W., Liou, G. I., Rinn, J., Chang, H., Caspi, R. R., Fong, L., & Anderson, M. S. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061864 · Cited by 275
Self-citationSTEIN-STREILEIN, J., & STREILEIN, J. W. (2002) · International Reviews of Immunology · doi:10.1080/08830180212066 · Cited by 218 · cited 1×
“It involvesmigration from the eye to the spleen of F4/80 antigen-presenting cells that interact with invariant natural killer T cells and B cells and culminates in elicitation of systemic regulatory immunity through induction of CD4 afferent and CD8 efferent Treg cells (reviewed in [4,6]).”
BackgroundOcular autoimmunity: the price of privilege?
Caspi, R. R. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00439.x · Cited by 162
Self-citationOcular Immunosuppressive Microenvironment
Taylor, A. W. (2007) · KARGER eBooks · doi:10.1159/000099255 · Cited by 160
Retinal Pigment Epithelium-Derived CTLA-2α Induces TGFβ-Producing T Regulatory Cells,
Sugita, S., Horie, S., Nakamura, O., Futagami, Y., Takase, H., Keino, H., Aburatani, H., Katunuma, N., Ishidoh, K., Yamamoto, Y., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.7525 · Cited by 126
Organ-Resident, Nonlymphoid Cells Suppress Proliferation of Autoimmune T-Helper Lymphocytes
Caspi, R. R., ROBERGE, F. G., & Nussenblatt, R. B. (1987) · Science · doi:10.1126/science.2956685 · Cited by 123
Self-citationSugita, S., Usui, Y., Horie, S., Futagami, Y., Aburatani, H., Okazaki, T., Honjo, T., Takeuchi, M., & Mochizuki, M. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2846 · Cited by 99
Cited by
VEGFR1 signaling in retinal angiogenesis and microinflammation
Uemura, A., Fruttiger, M., D'Amore, P. A., De Falco, S., Joussen, A. M., Sennlaub, F., Brunck, L. R., Johnson, K. T., Lambrou, G. N., Rittenhouse, K. D., et al. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100954 · Cited by 354
CHECKPOINT INHIBITOR IMMUNE THERAPY: Systemic Indications and Ophthalmic Side Effects
Dalvin, L. A., Shields, C. L., Orloff, M., Sato, T., & Shields, J. A. (2018) · Retina · doi:10.1097/iae.0000000000002181 · Cited by 336
Human Corneal Endothelial Cell Expansion for Corneal Endothelium Transplantation: An Overview
Peh, G. S. L., Beuerman, R. W., Colman, A., Tan, D. T., & Mehta, J. S. (2011) · Transplantation · doi:10.1097/tp.0b013e3182111f01 · Cited by 242
Immune mechanisms in inflammatory and degenerative eye disease
Perez, V. L., & Caspi, R. R. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.04.003 · Cited by 188
Self-citationGasparini, S. J., Llonch, S., Borsch, O., & Ader, M. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.11.001 · Cited by 186
Biodegradable Polymer-Based Drug-Delivery Systems for Ocular Diseases
Tsung, T., Tsai, Y.-C., Lee, H.-P., Chen, Y., & Lu, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612976 · Cited by 166
Good News–Bad News: The Yin and Yang of Immune Privilege in the Eye
Forrester, J. V., & Xu, H. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00338 · Cited by 153
Alzheimer’s Retinopathy: Seeing Disease in the Eyes
Mirzaei, N., Shi, H., Oviatt, M., Doustar, J., Rentsendorj, A., Fuchs, D.-T. S., Sheyn, J., Black, K. L., Koronyo, Y., & Koronyo‐Hamaoui, M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00921 · Cited by 145
HLA and proteasome expression body map
Boegel, S., Löwer, M., Bukur, T., Sorn, P., Castle, J. C., & Şahin, U. (2018) · BMC Medical Genomics · doi:10.1186/s12920-018-0354-x · Cited by 120
Ocular toxicities of MEK inhibitors and other targeted therapies
Stjepanovic, N., Velazquez-Martin, J. P., & Bedard, P. L. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw100 · Cited by 110
Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy
Bolinger, M. T., & Antonetti, D. A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091498 · Cited by 114
Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer
Baraibar, I., Melero, I., Ponz‐Sarvisé, M., & Álvarez, E. C. (2019) · Drug Safety · doi:10.1007/s40264-018-0774-8 · Cited by 112
Oculomics: Current concepts and evidence
Zhu, Z., Wang, Y., Qi, Z., Hu, W., Zhang, X., Wagner, S. K., Wang, Y., Ran, A. R., Ong, J., Waisberg, E., et al. (2025) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2025.101350 · Cited by 118
Salerno, E. P., Bedognetti, D., Mauldin, I. S., Deacon, D. H., Shea, S. M., Pinczewski, J., Obeid, J. M., Coukos, G., Wang, E., Gajewski, T. F., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1240857 · Cited by 98
Ocular Involvement in Systemic Autoimmune Diseases
Generali, E., Cantarini, L., & Selmi, C. F. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8518-3 · Cited by 91
L ‐DOPA‐Coated Manganese Oxide Nanoparticles as Dual MRI Contrast Agents and Drug‐Delivery Vehicles
McDonagh, B. H., Singh, G., Hak, S., Bandyopadhyay, S., Augestad, I. L., Peddis, D., Sandvig, I., Sandvig, A., & Glomm, W. R. (2015) · Small · doi:10.1002/smll.201502545 · Cited by 94
Gene therapy for inherited retinal diseases
Nuzbrokh, Y., Ragi, S. D., & Tsang, S. H. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-4726 · Cited by 94
Tissue tropism in parasitic diseases
Silva Pereira, S., Trindade, S., De Niz, M., & Figueiredo, L. M. (2019) · Open Biology · doi:10.1098/rsob.190036 · Cited by 85
Does autoimmunity play a part in the pathogenesis of glaucoma?
Bell, K. C., Gramlich, O. W., Hohenstein-Blaul, N. V. T. U., Gehrke-Beck, S., Funke, S., Wilding, C., Pfeiffer, N., & Grus, F. H. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.02.003 · Cited by 83
Perspectives of Molecularly Imprinted Polymer-Based Drug Delivery Systems in Cancer Therapy
Bodoki, A., Iacob, B., & Bodoki, E. (2019) · Polymers · doi:10.3390/polym11122085 · Cited by 85
LNP-mediated delivery of CRISPR RNP for wide-spread in vivo genome editing in mouse cornea
Mohanna, S. Z. M., Djaksigulova, D., Hill, A. M., Wagner, P. K., Simpson, E. M., & Leavitt, B. R. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.08.042 · Cited by 79
Mucosal plasma cells are required to protect the upper airway and brain from infection
Wellford, S. A., Moseman, A. P., Dao, K., Wright, K., Chen, A. P., Plevin, J. E., Liao, T.-C., Mehta, N. U., & Moseman, E. A. (2022) · Immunity · doi:10.1016/j.immuni.2022.08.017 · Cited by 78
Adeno-Associated Viruses (AAV) and Host Immunity – A Race Between the Hare and the Hedgehog
Rapti, K., & Grimm, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.753467 · Cited by 79
AAV for Gene Therapy in Ocular Diseases: Progress and Prospects
He, X., Fu, Y., Ma, L., Yao, Y., Ge, S., Yang, Z. H., & Fan, X. (2023) · Research · doi:10.34133/research.0291 · Cited by 79
Shi, H., Koronyo, Y., Fuchs, D.-T. S., Sheyn, J., Wawrowsky, K., Lahiri, S., Black, K. L., & Koronyo‐Hamaoui, M. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01076-4 · Cited by 72
In Vitro Immune Organs-on-Chip for Drug Development: A Review
Shanti, A., Teo, J. C. M., & Stefanini, C. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040278 · Cited by 74
Implications of genetic variation in the complement system in age-related macular degeneration
de Jong, S., Gagliardi, G., Garanto, A., de Breuk, A., Lechanteur, Y. T. E., Katti, S., van den Heuvel, L. P., Volokhina, E. B., & den Hollander, A. I. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100952 · Cited by 71
“The inner and outer blood-retinal barriers form a physical barrier supporting the immune privilege of the eye (Zhou and Caspi, 2010).”
BackgroundBomze, D., Meirson, T., Ali, O. H., Goldman, A., Flatz, L., & Habot‐Wilner, Z. (2020) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2020.1773867 · Cited by 72
Glucocorticoid receptor signaling in the eye
Sulaiman, R. S., Kadmiel, M., & Cidlowski, J. A. (2017) · Steroids · doi:10.1016/j.steroids.2017.11.002 · Cited by 75
Gene Therapy for Mitochondrial Diseases: Current Status and Future Perspective
Donfrancesco, A. D., Massaro, G., Meo, I. D., Tiranti, V., Bottani, E., & Brunetti, D. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061287 · Cited by 65
Lack of thrombospondin 1 and exacerbation of choroidal neovascularization
Wang, S., Sorenson, C. M., & Sheibani, N. (2012) · Archives of Ophthalmology · doi:10.1001/archopthalmol.2011.1892 · Cited by 61
Allergic Conjunctivitis: Review of Current Types, Treatments, and Trends
Tariq, F. (2024) · Life · doi:10.3390/life14060650 · Cited by 60
Ramlogan‐Steel, C. A., Murali, A., Andrzejewski, S., Dhungel, B., Steel, J. C., & Layton, C. J. (2019) · Clinical & Experimental Ophthalmology · doi:10.1111/ceo.13416 · Cited by 57
Giri, B. R., Jakka, D., Sandoval, M. A., Kulkarni, V. R., & Bao, Q. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16101325 · Cited by 64
Ilmarinen, T., Hiidenmaa, H., Kööbi, P., Nymark, S., Sorkio, A., Wang, J., Stanzel, B. V., Thieltges, F., Alajuuma, P., Oksala, O., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143669 · Cited by 63
Corneal tissue-resident memory T cells form a unique immune compartment at the ocular surface
Loi, J. K., Alexandre, Y. O., Senthil, K., Schienstock, D., Sandford, S., Devi, S., Christo, S. N., Mackay, L. K., Chinnery, H. R., Osborne, P. B., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110852 · Cited by 58
Menuchin-Lasowski, Y., Schreiber, A., Lecanda, A., Mecate‐Zambrano, A., Brunotte, L., Psathaki, O. E., Ludwig, S., Rauen, T., & Schöler, H. R. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.02.015 · Cited by 56
Torres, M. D. T., Cesaro, A., & de la Fuente‐Núñez, C. (2024) · Trends in biotechnology · doi:10.1016/j.tibtech.2024.09.008 · Cited by 53
Local Activation of Dendritic Cells Alters the Pathogenesis of Autoimmune Disease in the Retina
Heuss, N. D., Lehmann, U., Norbury, C. C., McPherson, S. W., & Gregerson, D. S. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101621 · Cited by 56
Humoral immune responses to AAV gene therapy in the ocular compartment
Whitehead, M., Osborne, A., Yu‐Wai‐Man, P., & Martin, K. (2021) · Biological Reviews · doi:10.1111/brv.12718 · Cited by 52
Genome engineering in ophthalmology: Application of CRISPR/Cas to the treatment of eye disease
Hung, S. S. C., McCaughey, T., Swann, O. G., Pébay, A., & Hewitt, A. W. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.05.001 · Cited by 54
Potential mechanisms of Zika‐linked microcephaly
Merfeld, E., Ben‐Avi, L., Kennon, M., & Cerveny, K. L. (2017) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.273 · Cited by 54
Kulbay, M., Marcotte, E., Remtulla, R., Lau, T. H. A., Paez-Escamilla, M. A., Wu, K. Y., & Burnier, M. N. (2024) · Biomedicines · doi:10.3390/biomedicines12081758 · Cited by 54
Gene correction in patient-specific iPSCs for therapy development and disease modeling
Jang, Y.-Y., & Ye, Z. (2016) · Human Genetics · doi:10.1007/s00439-016-1691-5 · Cited by 53
Faris, P. S., Negri, S., Perna, A., Rosti, V., Guerra, G., & Moccia, F. D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197406 · Cited by 51
Ocular Inflammation Induced by Immune Checkpoint Inhibitors
Chaudot, F., Sève, P., Rousseau, A., Maria, A. T. J., Fournié, P., Lozac’h, P., Keraen, J., Servant, M., Muller, R., Gramont, B., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11174993 · Cited by 49
Immunotherapeutic strategies in autoimmune uveitis
Papotto, P. H., Marengo, E. B., Sardinha, L. R., Goldberg, A. C., & Rizzo, L. V. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.05.003 · Cited by 47
Contemporary Animal Models For Human Gene Therapy Applications
Gopinath, C., Nathar, T. J., Ghosh, A., Hickstein, D. D., & Nelson, E. J. R. (2015) · Current Gene Therapy · doi:10.2174/1566523215666150929110424 · Cited by 49
Bilateral Anterior Uveitis Associated with Nivolumab Therapy
Karlin, J. N., Gentzler, R. D., & Golen, J. R. (2016) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2016.1215473 · Cited by 45
Armento, A., Schmidt, T. L., Sonntag, I., Merle, D. A., Jarboui, M. A., Kilger, E., Clark, S. J., & Ueffing, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168727 · Cited by 49
Zhou, Y., Wang, Y., Xia, R.-L., Liu, J., & Ma, X. (2022) · International Journal of Ophthalmology · doi:10.18240/ijo.2022.04.19 · Cited by 44
The role of teratogens in neural crest development
Cerrizuela, S., Vega‐López, G. A., & Aybar, M. J. (2020) · Birth Defects Research · doi:10.1002/bdr2.1644 · Cited by 46
The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Hu, X., Zhang, B., Li, X., Li, M., Wang, Y., Dan, H., Zhou, J., Wei, Y., Ge, K., Li, P., et al. (2022) · Eye · doi:10.1038/s41433-022-02169-1 · Cited by 42
Myeloid-derived suppressor cells in non-neoplastic inflamed organs
Sendo, S., Saegusa, J., & Morinobu, A. (2018) · Inflammation and Regeneration · doi:10.1186/s41232-018-0076-7 · Cited by 40
Retinal toxicities of systemic anticancer drugs
Arora, S., Surakiatchanukul, T., Arora, T., Errera, M. H., Agrawal, H., Lupidi, M., & Chhablani, J. (2021) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2021.05.007 · Cited by 42
Gene Expression and Functional Annotation of the Human Ciliary Body Epithelia
Janssen, S. F., Gorgels, T. G. M. F., Bossers, K., ten Brink, J. B., Essing, A. H. W., Nagtegaal, M., van der Spek, P. J., Jansonius, N. M., & Bergen, A. A. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044973 · Cited by 40
From waste to wealth: Repurposing slaughterhouse waste for xenotransplantation
Khan, R. L., Khraibi, A. A., Dumée, L. F., & Corridon, P. R. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1091554 · Cited by 41
Chambers, C., Soo, G. L., Engel, A. L., Glass, I. A., Frassetto, A., Martini, P. G. V., & Cherry, T. J. (2024) · Translational Vision Science & Technology · doi:10.1167/tvst.13.7.7 · Cited by 38
Kanno, H., Ishida, K., Yamada, W., Nishida, T., Takahashi, N., Mochizuki, K., Mizuno, Y., Matsuyama, K., Takahashi, T., & Seishima, M. (2017) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2017.04.007 · Cited by 38
Petrash, C. C., Palestine, A. G., & Canto-Soler, M. V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.621007 · Cited by 38
Translational vitreous proteomics
Mahajan, V. B., & Skeie, J. M. (2013) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201300062 · Cited by 37
Corneal Endothelial-like Cells Derived from Induced Pluripotent Stem Cells for Cell Therapy
Ng, X. Y., Peh, G. S. L., Yam, G. H., Tay, H. G., & Mehta, J. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512433 · Cited by 37
Trabecular Meshwork Regeneration—a Potential Treatment for Glaucoma
Castro, A. D., & Du, Y. (2019) · Current Ophthalmology Reports · doi:10.1007/s40135-019-00203-2 · Cited by 35
Fouda, A. Y., Xu, Z., Narayanan, S. P., Caldwell, R. W., & Caldwell, R. B. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.3.51 · Cited by 35
Singh, L., Singh, M. K., Kenney, M. C., Jager, M. J., Rizvi, M. M. A., Meel, R., Lomi, N., Bakhshi, S., Sen, S., & Kashyap, S. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02773-8 · Cited by 35
Dludla, S. B. K., Mashabela, L. T., Ng’andwe, B., Makoni, P. A., & Witika, B. A. (2022) · Polymers · doi:10.3390/polym14173580 · Cited by 39
Next generation therapeutics for retinal neurodegenerative diseases
Appell, M. B., Pejavar, J., Pasupathy, A., Rompicharla, S. V. K., Abbasi, S., Malmberg, K., Kolodziejski, P., & Ensign, L. M. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.01.063 · Cited by 34
Wang, W., Lam, W., & Chen, L. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2260-7 · Cited by 34
Somboonpatarakun, C., Intapan, P. M., Sadaow, L., Rodpai, R., Sanpool, O., & Maleewong, W. (2019) · Parasitology · doi:10.1017/s0031182019001495 · Cited by 34
Revolution in Gene Medicine Therapy and Genome Surgery
Jiang, D. J., Xu, C. L., & Tsang, S. H. (2018) · Genes · doi:10.3390/genes9120575 · Cited by 34
Perspectives of Molecularly Imprinted Polymer-Based Drug Delivery Systems in Ocular Therapy
Bodoki, A., Iacob, B., Dinte, E., Voștinaru, O., Samoilă, O., & Bodoki, E. (2021) · Polymers · doi:10.3390/polym13213649 · Cited by 34
Targeted Cancer Therapy and Its Ophthalmic Side Effects: A Review
Bindiganavile, S. H., Bhat, N., Lee, A. G., Gombos, D. S., & Al-Zubidi, N. S. (2021) · Journal of Immunotherapy and Precision Oncology · doi:10.36401/jipo-20-21 · Cited by 33
Nuzbrokh, Y., Kassotis, A. S., Ragi, S. D., Jauregui, R., & Tsang, S. H. (2020) · Ophthalmology and Therapy · doi:10.1007/s40123-020-00287-1 · Cited by 31
Infectious Uveitis in Horses and New Insights in Its Leptospiral Biofilm-Related Pathogenesis
Wollanke, B., Gerhards, H., & Ackermann, K. (2022) · Microorganisms · doi:10.3390/microorganisms10020387 · Cited by 33
Jasinski‐Bergner, S., Eckstein, M., Taubert, H., Wach, S., Fiebig, C., Strick, R., Hartmann, A., & Seliger, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.811200 · Cited by 30
Thomason, C. A., Leon, A. E., Kirkpatrick, L. T., Belden, L. K., & Hawley, D. M. (2016) · Environmental Microbiology · doi:10.1111/1462-2920.13625 · Cited by 29
Non-Primate Lentiviral Vectors and Their Applications in Gene Therapy for Ocular Disorders
Cavalieri, V., Baiamonte, E., & Iacono, M. L. (2018) · Viruses · doi:10.3390/v10060316 · Cited by 32
Investigation of Cas9 Antibodies in the Human Eye
Toral, M. A., Charlesworth, C. T., Ng, B., Chemudupati, T., Homma, S., Nakauchi, H., Bassuk, A. G., Porteus, M. H., & Mahajan, V. B. (2022) · Nature Communications · doi:10.1038/s41467-022-28674-1 · Cited by 28
Almost famous: Human adenoviruses (and what they have taught us about cancer)
Tessier, T. M., Dodge, M. J., MacNeil, K. M., Evans, A. M., Prusinkiewicz, M. A., & Mymryk, J. S. (2021) · Tumour Virus Research · doi:10.1016/j.tvr.2021.200225 · Cited by 29
Sundaresan, Y., Yacoub, S., Kodati, B., Amankwa, C. E., Raola, A., & Zode, G. S. (2023) · FEBS Journal · doi:10.1111/febs.16771 · Cited by 29
S-layer Impacts the Virulence of Bacillus in Endophthalmitis
Mursalin, M. H., Coburn, P. S., Livingston, E. T., Miller, F. C., Astley, R., Fouet, A., & Callegan, M. C. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.19-27453 · Cited by 26
Lens regeneration in humans: using regenerative potential for tissue repairing
Liu, Z., Wang, R., Lin, H., & Liu, Y. (2020) · Annals of Translational Medicine · doi:10.21037/atm-2019-rcs-03 · Cited by 31
Neuroretinal-Derived Caveolin-1 Promotes Endotoxin-Induced Inflammation in the Murine Retina
Gurley, J. M., Gmyrek, G. B., McClellan, M. E., Hargis, E. A., Hauck, S. M., Dozmorov, M. G., Wren, J. D., Carr, D. J. J., & Elliott, M. H. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.12.19 · Cited by 25
Bilateral multiple serous retinal detachments after treatment with nivolumab: a case report
Miyamoto, R., Nakashizuka, H., Tanaka, K., Wakatsuki, Y., Onoe, H., Mori, R., & Kawamura, A. (2020) · BMC Ophthalmology · doi:10.1186/s12886-020-01495-w · Cited by 25
Therapeutic targeting of the complement system in ocular disease
Rathi, S., Hasan, R., Ueffing, M., & Clark, S. J. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103757 · Cited by 24
Ford, J. L., Karatza, E., Mody, H. R., Shastri, P. N., Khajehpour, S., Yang, T., Swanson, M., Chao, D. L., & Devineni, D. (2024) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.3230 · Cited by 25
Tapping Stem Cells to Target AMD: Challenges and Prospects
Brandl, C., Graßmann, F., Riolfi, J., & Weber, B. H. F. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4020282 · Cited by 27
Szatmári-Tóth, M., Ilmarinen, T., Mikhailova, A., Skottman, H., Kauppinen, A., Kaarniranta, K., Kristóf, E., Lytvynchuk, L. M., Veréb, Z., Fésüs, L., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040926 · Cited by 24
Gene Therapy to the Retina and the Cochlea
Crane, R., Conley, S. M., Al‐Ubaidi, M. R., & Naash, M. I. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.652215 · Cited by 25
Galletti, J. G., & de Paiva, C. S. (2021) · Immunology · doi:10.1111/imm.13338 · Cited by 24
Shityakov, S., Nagai, M., Ergün, S., Braunger, B. M., & Förster, C. Y. (2022) · Biomolecules · doi:10.3390/biom12081113 · Cited by 24
Singh, S., Singh, P. K., & Kumar, A. (2022) · Infection and Immunity · doi:10.1128/iai.00252-22 · Cited by 24
The Application of CRISPR/Cas9 for the Treatment of Retinal Diseases.
Peddle, C. F., & MacLaren, R. E. (2017) · PubMed Central · Cited by 33
The eye as a novel imaging site in diabetes research
Yang, S.-N., & Berggren, P. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.01.005 · Cited by 24
Jehs, T., Faber, C., Udsen, M. S., Jager, M. J., Clark, S. J., & Nissen, M. H. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-18524 · Cited by 23
Shirahama, S., Okunuki, Y., Lee, M. Y., Karg, M. M., Refaian, N., Krasniqi, D., Connor, K. M., Gregory-Ksander, M. S., & Ksander, B. R. (2024) · Journal of Autoimmunity · doi:10.1016/j.jaut.2025.103417 · Cited by 22
Inflammatory Ocular Diseases and Sphingolipid Signaling
Grambergs, R. C., Mondal, K., & Mandal, N. A. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-21162-2_8 · Cited by 22
Immune-mediated adverse effects of immune-checkpoint inhibitors and their management in cancer
Jin, K., Wang, S., Ying, X., Lan, H., Lv, J., Zhang, L.-H., Motallebnezhad, M., & Mou, X. (2020) · Immunology Letters · doi:10.1016/j.imlet.2020.02.008 · Cited by 24
Valero, Y., Boughlala, B., Arizcún, M., Patel, S., Fiksdal, I. U., Esteban, M. Á., Juan, J. D., Meseguer, J., Chaves-Pozo, E., & Cuesta, A. (2018) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2018.01.034 · Cited by 22
Chen, K.-S., Chan, H.-C., & Chan, C.-M. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.14.53 · Cited by 21
Metadata
- Authors
- Zhou, R., & Caspi, R. R.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Caspi, Rachel R
- Venue
- F1000 Biology Reports
- Publisher
- H1 Connect
- Published
- 2010-01-18
- Volume
- 2
- ISSN
- 1757-594X (ISSN-L)
- DOI
- 10.3410/b2-3
- PMC
- PMC2948372
- OpenAlex
- W2132060134
- Cited by
- 259
- References
- 18
- Citations by year
- 2026: 10 · 2025: 25 · 2024: 32 · 2023: 23 · 2022: 31 · 2021: 23 · 2020: 31 · 2019: 14 · 2018: 22 · 2017: 14 · 2016: 11 · 2015: 9 · 2014: 2 · 2013: 2 · 2012: 7
- FWCI
- 4.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- F1000 Biology Reports (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- ocular immune privilege, eye, inflammation, vision preservation, local immune regulation, ocular immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.